ID

39592

Description

Phase II Cancer Vaccine Trial for Patients With Follicular Lymphoma; ODM derived from: https://clinicaltrials.gov/show/NCT01926639

Lien

https://clinicaltrials.gov/show/NCT01926639

Mots-clés

Versions (1)
  1. 01/02/2020 01/02/2020 -
Détendeur de droits

See clinicaltrials.gov

Téléchargé le

1 février 2020

DOI

Pour une demande vous connecter.

Licence

Creative Commons BY 4.0
Modèle Commentaires :

Ici, vous pouvez faire des commentaires sur le modèle. À partir des bulles de texte, vous pouvez laisser des commentaires spécifiques sur les groupes Item et les Item.

Retour au modèle Commentaires
Groupe Item commentaires pour :

Item commentaires pour :

Vous devez être connecté pour pouvoir télécharger des formulaires. Veuillez vous connecter ou s’inscrire gratuitement.

Eligibility Follicular Lymphoma NCT01926639

Anglais

Eligibility Follicular Lymphoma NCT01926639

1 Formulaires  
Inclusion Criteria
Description

Inclusion Criteria

Alias
UMLS CUI
C1512693
1. age 18 years and older
Description

Age

Type de données

boolean

Alias
UMLS CUI [1]
C0001779
2. histologically confirmed (by who classification) untreated and relapsed indolent non-hodgkin's b-cell lymphoma of low-grade follicular, marginal zone, lymphoplasmocytic or small lymphocytic subtypes.
Description

Recurrent Indolent Adult Non-Hodgkin Lymphoma Untreated WHO classification | Follicular Lymphoma low grade | Marginal Zone B-Cell Lymphoma | Lymphoplasmacytic lymphoma | Small Lymphocytic Lymphoma

Type de données

boolean

Alias
UMLS CUI [1,1]
C0677723
UMLS CUI [1,2]
C0332155
UMLS CUI [1,3]
C4267671
UMLS CUI [2,1]
C0024301
UMLS CUI [2,2]
C1282907
UMLS CUI [3]
C1367654
UMLS CUI [4]
C0024419
UMLS CUI [5]
C0855095
3. stage iii/iv
Description

Ann Arbor lymphoma staging system

Type de données

boolean

Alias
UMLS CUI [1]
C0432516
4. adequate bone marrow function (leukocyte count>2,0, neutrophil count>1.0, platelets>50)
Description

Bone Marrow function | White Blood Cell Count procedure | Neutrophil count | Platelet Count measurement

Type de données

boolean

Alias
UMLS CUI [1,1]
C0005953
UMLS CUI [1,2]
C0031843
UMLS CUI [2]
C0023508
UMLS CUI [3]
C0200633
UMLS CUI [4]
C0032181
5. two or more separate lymph nodes > 1,5 cm available for biopsy or treatment.
Description

Lymph nodes Quantity Biopsy | Lymph nodes Quantity Therapeutic procedure | Size of lymph node

Type de données

boolean

Alias
UMLS CUI [1,1]
C0024204
UMLS CUI [1,2]
C1265611
UMLS CUI [1,3]
C0005558
UMLS CUI [2,1]
C0024204
UMLS CUI [2,2]
C1265611
UMLS CUI [2,3]
C0087111
UMLS CUI [3]
C1285847
6. measurable disease present other than biopsy site and injection site(s).
Description

Measurable Disease | Exception Biopsy Site | Exception Injection Site

Type de données

boolean

Alias
UMLS CUI [1]
C1513041
UMLS CUI [2,1]
C1705847
UMLS CUI [2,2]
C0005558
UMLS CUI [2,3]
C1515974
UMLS CUI [3,1]
C1705847
UMLS CUI [3,2]
C1533685
UMLS CUI [3,3]
C1515974
7. required wash-out period after previous treatment: chemotherapy - 8 weeks, radiotherapy - 4 weeks, rituximab - 12 weeks
Description

Washout Period Required | Status post Prior Therapy | Chemotherapy | Therapeutic radiology procedure | rituximab

Type de données

boolean

Alias
UMLS CUI [1,1]
C1710661
UMLS CUI [1,2]
C1514873
UMLS CUI [2,1]
C0231290
UMLS CUI [2,2]
C1514463
UMLS CUI [3]
C0392920
UMLS CUI [4]
C1522449
UMLS CUI [5]
C0393022
8. who status 0-1
Description

WHO performance status scale

Type de données

boolean

Alias
UMLS CUI [1]
C1298650
9. life expectancy of more than 6 months
Description

Life Expectancy

Type de données

boolean

Alias
UMLS CUI [1]
C0023671
10. written informed consent
Description

Informed Consent

Type de données

boolean

Alias
UMLS CUI [1]
C0021430
11. able to comply with the treatment protocol -
Description

Treatment Compliance

Type de données

boolean

Alias
UMLS CUI [1]
C4319828
Exclusion Criteria
Description

Exclusion Criteria

Alias
UMLS CUI
C0680251
1. patients with progressive lymphoma in need of systemic therapy or standard dose irradiation.
Description

Lymphoma Progressive | Patient need for Systemic therapy | Patient need for Irradiation Standard Dose

Type de données

boolean

Alias
UMLS CUI [1,1]
C0024299
UMLS CUI [1,2]
C0205329
UMLS CUI [2,1]
C0686904
UMLS CUI [2,2]
C1515119
UMLS CUI [3,1]
C0686904
UMLS CUI [3,2]
C1522449
UMLS CUI [3,3]
C1442989
UMLS CUI [3,4]
C0178602
2. chronic bacterial, viral or fungal infection
Description

Bacterial Infection chronic | Virus Disease chronic | Mycoses chronic

Type de données

boolean

Alias
UMLS CUI [1,1]
C0004623
UMLS CUI [1,2]
C0205191
UMLS CUI [2,1]
C0042769
UMLS CUI [2,2]
C0205191
UMLS CUI [3,1]
C0026946
UMLS CUI [3,2]
C0205191
3. pre-existing autoimmune or antibody mediated disease including: systemic lupus, erythematosus, rheumatoid arthritis, multiple sclerosis, sjogren's syndrome, autoimmune thrombocytopenia, but excluding controlled thyroid disease, or the presence of autoantibodies without clinical autoimmune disease.
Description

Autoimmune Disease Pre-existing | Disease Due to Antibodies | Lupus Erythematosus, Systemic | Rheumatoid Arthritis | Multiple Sclerosis | Sjogren's Syndrome | Autoimmune thrombocytopenia | Exception Thyroid Disease Controlled | Exception Autoantibodies Without Autoimmune Diseases

Type de données

boolean

Alias
UMLS CUI [1,1]
C0004364
UMLS CUI [1,2]
C2347662
UMLS CUI [2,1]
C0012634
UMLS CUI [2,2]
C0678226
UMLS CUI [2,3]
C0003241
UMLS CUI [3]
C0024141
UMLS CUI [4]
C0003873
UMLS CUI [5]
C0026769
UMLS CUI [6]
C1527336
UMLS CUI [7]
C0242584
UMLS CUI [8,1]
C1705847
UMLS CUI [8,2]
C0040128
UMLS CUI [8,3]
C2911690
UMLS CUI [9,1]
C1705847
UMLS CUI [9,2]
C0004358
UMLS CUI [9,3]
C0332288
UMLS CUI [9,4]
C0004364
4. known history of hiv
Description

HIV Infection

Type de données

boolean

Alias
UMLS CUI [1]
C0019693
5. central nervous system involvement of lymphoma
Description

Central Nervous System Involvement Lymphoma

Type de données

boolean

Alias
UMLS CUI [1,1]
C4050309
UMLS CUI [1,2]
C0024299
6. current anticoagulant therapy which can not safely be paused during treatment injections (asa < 325 mg/day allowed)
Description

Anticoagulant therapy Discontinuation Unsuccessful | Aspirin U/day allowed

Type de données

boolean

Alias
UMLS CUI [1,1]
C0150457
UMLS CUI [1,2]
C1444662
UMLS CUI [1,3]
C1272705
UMLS CUI [2,1]
C0004057
UMLS CUI [2,2]
C0456683
UMLS CUI [2,3]
C0683607
7. pregnancy -
Description

Pregnancy

Type de données

boolean

Alias
UMLS CUI [1]
C0032961
Retour au début de la page

Similar models

Eligibility Follicular Lymphoma NCT01926639

1 Formulaires
Name
Type
Description | Question | Decode (Coded Value)
Type de données
Alias
Item Group
C1512693 (UMLS CUI)
Age
Item
1. age 18 years and older
boolean
C0001779 (UMLS CUI [1])
Recurrent Indolent Adult Non-Hodgkin Lymphoma Untreated WHO classification | Follicular Lymphoma low grade | Marginal Zone B-Cell Lymphoma | Lymphoplasmacytic lymphoma | Small Lymphocytic Lymphoma
Item
2. histologically confirmed (by who classification) untreated and relapsed indolent non-hodgkin's b-cell lymphoma of low-grade follicular, marginal zone, lymphoplasmocytic or small lymphocytic subtypes.
boolean
C0677723 (UMLS CUI [1,1])
C0332155 (UMLS CUI [1,2])
C4267671 (UMLS CUI [1,3])
C0024301 (UMLS CUI [2,1])
C1282907 (UMLS CUI [2,2])
C1367654 (UMLS CUI [3])
C0024419 (UMLS CUI [4])
C0855095 (UMLS CUI [5])
Ann Arbor lymphoma staging system
Item
3. stage iii/iv
boolean
C0432516 (UMLS CUI [1])
Bone Marrow function | White Blood Cell Count procedure | Neutrophil count | Platelet Count measurement
Item
4. adequate bone marrow function (leukocyte count>2,0, neutrophil count>1.0, platelets>50)
boolean
C0005953 (UMLS CUI [1,1])
C0031843 (UMLS CUI [1,2])
C0023508 (UMLS CUI [2])
C0200633 (UMLS CUI [3])
C0032181 (UMLS CUI [4])
Lymph nodes Quantity Biopsy | Lymph nodes Quantity Therapeutic procedure | Size of lymph node
Item
5. two or more separate lymph nodes > 1,5 cm available for biopsy or treatment.
boolean
C0024204 (UMLS CUI [1,1])
C1265611 (UMLS CUI [1,2])
C0005558 (UMLS CUI [1,3])
C0024204 (UMLS CUI [2,1])
C1265611 (UMLS CUI [2,2])
C0087111 (UMLS CUI [2,3])
C1285847 (UMLS CUI [3])
Measurable Disease | Exception Biopsy Site | Exception Injection Site
Item
6. measurable disease present other than biopsy site and injection site(s).
boolean
C1513041 (UMLS CUI [1])
C1705847 (UMLS CUI [2,1])
C0005558 (UMLS CUI [2,2])
C1515974 (UMLS CUI [2,3])
C1705847 (UMLS CUI [3,1])
C1533685 (UMLS CUI [3,2])
C1515974 (UMLS CUI [3,3])
Washout Period Required | Status post Prior Therapy | Chemotherapy | Therapeutic radiology procedure | rituximab
Item
7. required wash-out period after previous treatment: chemotherapy - 8 weeks, radiotherapy - 4 weeks, rituximab - 12 weeks
boolean
C1710661 (UMLS CUI [1,1])
C1514873 (UMLS CUI [1,2])
C0231290 (UMLS CUI [2,1])
C1514463 (UMLS CUI [2,2])
C0392920 (UMLS CUI [3])
C1522449 (UMLS CUI [4])
C0393022 (UMLS CUI [5])
WHO performance status scale
Item
8. who status 0-1
boolean
C1298650 (UMLS CUI [1])
Life Expectancy
Item
9. life expectancy of more than 6 months
boolean
C0023671 (UMLS CUI [1])
Informed Consent
Item
10. written informed consent
boolean
C0021430 (UMLS CUI [1])
Treatment Compliance
Item
11. able to comply with the treatment protocol -
boolean
C4319828 (UMLS CUI [1])
Item Group
C0680251 (UMLS CUI)
Lymphoma Progressive | Patient need for Systemic therapy | Patient need for Irradiation Standard Dose
Item
1. patients with progressive lymphoma in need of systemic therapy or standard dose irradiation.
boolean
C0024299 (UMLS CUI [1,1])
C0205329 (UMLS CUI [1,2])
C0686904 (UMLS CUI [2,1])
C1515119 (UMLS CUI [2,2])
C0686904 (UMLS CUI [3,1])
C1522449 (UMLS CUI [3,2])
C1442989 (UMLS CUI [3,3])
C0178602 (UMLS CUI [3,4])
Bacterial Infection chronic | Virus Disease chronic | Mycoses chronic
Item
2. chronic bacterial, viral or fungal infection
boolean
C0004623 (UMLS CUI [1,1])
C0205191 (UMLS CUI [1,2])
C0042769 (UMLS CUI [2,1])
C0205191 (UMLS CUI [2,2])
C0026946 (UMLS CUI [3,1])
C0205191 (UMLS CUI [3,2])
Autoimmune Disease Pre-existing | Disease Due to Antibodies | Lupus Erythematosus, Systemic | Rheumatoid Arthritis | Multiple Sclerosis | Sjogren's Syndrome | Autoimmune thrombocytopenia | Exception Thyroid Disease Controlled | Exception Autoantibodies Without Autoimmune Diseases
Item
3. pre-existing autoimmune or antibody mediated disease including: systemic lupus, erythematosus, rheumatoid arthritis, multiple sclerosis, sjogren's syndrome, autoimmune thrombocytopenia, but excluding controlled thyroid disease, or the presence of autoantibodies without clinical autoimmune disease.
boolean
C0004364 (UMLS CUI [1,1])
C2347662 (UMLS CUI [1,2])
C0012634 (UMLS CUI [2,1])
C0678226 (UMLS CUI [2,2])
C0003241 (UMLS CUI [2,3])
C0024141 (UMLS CUI [3])
C0003873 (UMLS CUI [4])
C0026769 (UMLS CUI [5])
C1527336 (UMLS CUI [6])
C0242584 (UMLS CUI [7])
C1705847 (UMLS CUI [8,1])
C0040128 (UMLS CUI [8,2])
C2911690 (UMLS CUI [8,3])
C1705847 (UMLS CUI [9,1])
C0004358 (UMLS CUI [9,2])
C0332288 (UMLS CUI [9,3])
C0004364 (UMLS CUI [9,4])
HIV Infection
Item
4. known history of hiv
boolean
C0019693 (UMLS CUI [1])
Central Nervous System Involvement Lymphoma
Item
5. central nervous system involvement of lymphoma
boolean
C4050309 (UMLS CUI [1,1])
C0024299 (UMLS CUI [1,2])
Anticoagulant therapy Discontinuation Unsuccessful | Aspirin U/day allowed
Item
6. current anticoagulant therapy which can not safely be paused during treatment injections (asa < 325 mg/day allowed)
boolean
C0150457 (UMLS CUI [1,1])
C1444662 (UMLS CUI [1,2])
C1272705 (UMLS CUI [1,3])
C0004057 (UMLS CUI [2,1])
C0456683 (UMLS CUI [2,2])
C0683607 (UMLS CUI [2,3])
Pregnancy
Item
7. pregnancy -
boolean
C0032961 (UMLS CUI [1])
Retour au début de la page 

Contact

Utilisez ce formulaire pour les retours, les questions et les améliorations suggérées.

Les champs marqués d’un * sont obligatoires.

Aide

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial